Proteins and Peptides

12 Apr 2007 Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
11 Apr 2007 Stem Cell Therapeutics Corp. Announces Positive Interim Results From its Currently Enrolling Phase IIa Clinical Program for NTx(TM)-265 in Acute Stroke
06 Apr 2007 PEGINTRON(TM) Approved in China for Treating Chronic Hepatitis B
05 Apr 2007 Eurand Announces Positive Phase III Clinical Study Results
04 Apr 2007 Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
04 Apr 2007 New Data Confirm That Use of Levemir Can Limit Weight Gain
04 Apr 2007 Targanta Reports Improved Ability of Oritavancin to Stop Bacteria Growth In Vitro Compared With Other Glycopeptide Antibiotics
03 Apr 2007 Nautilus Biotech begins Phase I clinical trial in the USA for subcutaneous Belerofon(R) its long-lasting, Interferon-alpha drug.
03 Apr 2007 Helix BioPharma Corp. announces positive phase II clinical results with its Topical Interferon Alpha-2b
03 Apr 2007 Roche acquires THP to expand its therapeutic antibody research
03 Apr 2007 Diosynth Biotechnology Announces Agreement with Talecris Biotherapeutics for Process Development and Clinical Production of Recombinant Plasminogen
31 Mar 2007 RegeneRx Files IND to Begin Phase 2 Ophthalmic Clinical Trial
31 Mar 2007 Baxter Announces FDA Approval of CEPROTIN for Severe Congenital Protein C Deficiency
30 Mar 2007 Proteo, Inc./Proteo Biotech AG: European Commission grants Orphan Drug Status to Elafin for the treatment of PAH
30 Mar 2007 Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
30 Mar 2007 Gloucester Pharmaceuticals' Development of Romidepsin for Cutaneous T-Cell Lymphoma Continues Following Planned Review by Data Safety Monitoring Board
30 Mar 2007 Pieris Demonstrates Potent Anti-Tumor Activity of a VEGF-Specific Anticalin(R) in Preclinical Studies
29 Mar 2007 Protox Initiates Phase I Study of PRX302 for Benign Prostatic Hyperplasia
28 Mar 2007 CoGenesys, Inc. Expands Clinical Programs with Initiation of Phase 1-2a Trial of Neugranin in Cancer Patients
27 Mar 2007 Novartis to launch its own branded version of a leading multiple sclerosis therapy through agreement with Bayer Schering Pharma
27 Mar 2007 Wyeth Receives FDA Approval for New BeneFIX Features That Provide Hemophilia B Patients a Simpler and More Convenient Preparation Process for Recombinant Factor IX
27 Mar 2007 CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume in Coronary Arteries
27 Mar 2007 ACUITY One-Year Findings Meet All Primary Endpoints in Favor of Angiomax(R) (Bivalirudin) Alone Treatment Group
26 Mar 2007 Scios Announces Results From Exploratory Nesiritide Study Providing Important New Renal and Mortality Safety Data with a Neutral Effect on the Primary Endpoint
23 Mar 2007 Æterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up